Tal Zaks is a Partner, Private Equity at OrbiMed where he invests across Seed to Series D stages in the United States, Europe, and Asia, focusing on Biotechnology, Life Sciences, Healthcare, Pharmaceuticals, Genomic Medicines, and areas including Oncology, Autoimmune, Inflammatory, Metabolic, and Neurodegenerative diseases. He serves on the boards of Minervax ApS, Convergent Therapeutics, Inc., PIC Therapeutics, iECURE, inc., and Teva Pharmaceuticals, and has invested in companies like Convergent Therapeutics, Minervax, iECURE, PIC Therapeutics, and Capstan Therapeutics. Before OrbiMed, he was Chief Medical Officer at Moderna Therapeutics, a Non-Executive Director at Adaptimmune US, a Venture Partner at OrbiMed, and an Adjunct Associate Professor of Medicine at the University of Pennsylvania. Tal graduated from Ben-Gurion University of the Negev and lives in Newton, Massachusetts, United States.
Tal Zaks, Partner @ OrbiMed. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Tal Zaks from OrbiMed. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Tal
Map your path to Tal instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Tal
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.